Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Piazza

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
MicroRNA and cancer chemopreventionBin Yi, Gary A Piazza, Xiulan Su, et al.
Cancer Research|January 8, 2017
The RAS-Effector Interaction as a Drug TargetAdam B Keeton, E Alan Salter, Gary A Piazza
Frontiers in Oncology|September 25, 2025
Editorial: RAS inhibitor therapy of cancerDonald J Buchsbaum, Nicolas N Nassar, Gary A Piazza
Current Pharmacology Reports|July 28, 2015
Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory DrugsRuixia Ma, Bin Yi, Gary A Piazza, et al.
Cancers|March 1, 2014
The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentAlexandra M Fajardo, Gary A Piazza, Heather N Tinsley
Acta Pharmacologica Sinica|October 15, 2013
MicroRNAs are involved in the self-renewal and differentiation of cancer stem cellsZheng-ming Wang, Wen-jun Du, Gary A Piazza, et al.
Frontiers in Oncology|July 9, 2024
Assessment of KRAS<sup>G12C</sup> inhibitors for colorectal cancerGary A Piazza, Preethi Chandrasekaran, Yulia Y Maxuitenko, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2022
The path to the clinic: a comprehensive review on direct KRAS<sup>G12C</sup> inhibitorsAlbert K Kwan, Gary A Piazza, Adam B Keeton, et al.
European Journal of Medicinal Chemistry|April 16, 2013
Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agentsReem K Arafa, Gehan H Hegazy, Gary A Piazza, et al.
Acta Pharmacologica Sinica|February 5, 2013
Hypoxia-regulated microRNAs in human cancerGuomin Shen, Xiaobo Li, Yong-feng Jia, et al.
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Cancer Prevention Research (Philadelphia, Pa.)|March 28, 2013
MicroRNA and cancer chemopreventionBin Yi, Gary A Piazza, Xiulan Su, et al.
Cancer Research|January 8, 2017
The RAS-Effector Interaction as a Drug TargetAdam B Keeton, E Alan Salter, Gary A Piazza
Frontiers in Oncology|September 25, 2025
Editorial: RAS inhibitor therapy of cancerDonald J Buchsbaum, Nicolas N Nassar, Gary A Piazza
Current Pharmacology Reports|July 28, 2015
Mechanistic Role of MicroRNA in Cancer Chemoprevention by Nonsteroidal Anti-inflammatory DrugsRuixia Ma, Bin Yi, Gary A Piazza, et al.
Cancers|March 1, 2014
The role of cyclic nucleotide signaling pathways in cancer: targets for prevention and treatmentAlexandra M Fajardo, Gary A Piazza, Heather N Tinsley
Acta Pharmacologica Sinica|October 15, 2013
MicroRNAs are involved in the self-renewal and differentiation of cancer stem cellsZheng-ming Wang, Wen-jun Du, Gary A Piazza, et al.
Frontiers in Oncology|July 9, 2024
Assessment of KRAS<sup>G12C</sup> inhibitors for colorectal cancerGary A Piazza, Preethi Chandrasekaran, Yulia Y Maxuitenko, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 20, 2022
The path to the clinic: a comprehensive review on direct KRAS<sup>G12C</sup> inhibitorsAlbert K Kwan, Gary A Piazza, Adam B Keeton, et al.
European Journal of Medicinal Chemistry|April 16, 2013
Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agentsReem K Arafa, Gehan H Hegazy, Gary A Piazza, et al.
Acta Pharmacologica Sinica|February 5, 2013
Hypoxia-regulated microRNAs in human cancerGuomin Shen, Xiaobo Li, Yong-feng Jia, et al.
Pageof 12